Literature DB >> 10915810

Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone.

Y Huang1, G Brodda-Jansen, T Lundeberg, L C Yu.   

Abstract

The present study investigated the role of calcitonin gene-related peptide (CGRP) on nociception in nucleus raphe magnus (NRM) and the interaction between CGRP and opioid peptides in NRM of rats. CGRP-like immunoreactivity was found at a concentration of 6.0+/-0. 77 pmol/g in NRM tissue of ten samples of rats, suggesting that it may contribute to physiological responses orchestrated by the NRM. The hindpaw withdrawal latency (HWL) to thermal and mechanical stimulation increased significantly after intra-NRM administration of 0.5 or 1 nmol of CGRP in rats, but not 0.25 nmol. The anti-nociceptive effect induced by CGRP was antagonized by following intra-NRM injection of 1 nmol of the CGRP receptor antagonist CGRP8-37. Furthermore, the CGRP-induced anti-nociceptive effect was attenuated by following intra-NRM administration of 6 nmol of naloxone. The results indicate that CGRP and its receptors play an important role in anti-nociception, and there is a possible interaction between CGRP and opioid peptides in NRM of rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10915810     DOI: 10.1016/s0006-8993(00)02473-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  CGRP as a neuropeptide in migraine: lessons from mice.

Authors:  Andrew F Russo
Journal:  Br J Clin Pharmacol       Date:  2015-07-14       Impact factor: 4.335

Review 2.  CGRP receptor antagonism and migraine.

Authors:  Lars Edvinsson; Tony W Ho
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

3.  Effect of CGRP and sumatriptan on the BOLD response in visual cortex.

Authors:  Mohammad S Asghar; Adam E Hansen; Henrik B W Larsson; Jes Olesen; Messoud Ashina
Journal:  J Headache Pain       Date:  2012-01-14       Impact factor: 7.277

Review 4.  Calcitonin gene-related peptide (CGRP): a new target for migraine.

Authors:  Andrew F Russo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-08       Impact factor: 13.820

Review 5.  CGRP and its receptors provide new insights into migraine pathophysiology.

Authors:  Tony W Ho; Lars Edvinsson; Peter J Goadsby
Journal:  Nat Rev Neurol       Date:  2010-09-07       Impact factor: 42.937

Review 6.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

7.  Role of central calcitonin gene-related peptide (CGRP) in locomotor and anxiety- and depression-like behaviors in two mouse strains exhibiting a CGRP-dependent difference in thermal pain sensitivity.

Authors:  Ara Schorscher-Petcu; Jean-Sébastien Austin; Jeffrey S Mogil; Rémi Quirion
Journal:  J Mol Neurosci       Date:  2009-04-18       Impact factor: 3.444

Review 8.  CGRP in Animal Models of Migraine.

Authors:  Anne-Sophie Wattiez; Mengya Wang; Andrew F Russo
Journal:  Handb Exp Pharmacol       Date:  2019

9.  Neurochemical properties of BDNF-containing neurons projecting to rostral ventromedial medulla in the ventrolateral periaqueductal gray.

Authors:  Jun-Bin Yin; Huang-Hui Wu; Yu-Lin Dong; Ting Zhang; Jian Wang; Yong Zhang; Yan-Yan Wei; Ya-Cheng Lu; Sheng-Xi Wu; Wen Wang; Yun-Qing Li
Journal:  Front Neural Circuits       Date:  2014-11-20       Impact factor: 3.492

10.  Calcitonin gene-related peptide receptor antagonists: beyond migraine pain--a possible analgesic strategy for osteoarthritis?

Authors:  C M Bullock; S Kelly
Journal:  Curr Pain Headache Rep       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.